(S)-(-)-Bromofosfamide (CBM-11): Synthesis and antitumor activity and toxicity in mice

Anti-Cancer Drugs

Volumn 12, Issue 5, 2001, Pages 453-458

  Misiura, Konrad ^a   Kinas, Ryszard W ^a   Kuśnierczyk, Halina ^b   Radzikowski, Czeslaw ^b   Stec, Wojciech J ^a  

^a CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Alkylating agents; Anticancer drugs; Bromofosfamide; Oxazaphosphorine

Indexed keywords

ALKYLATING AGENT; BROMOFOSFAMIDE; CBM 11; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE DERIVATIVE; IFOSFAMIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; EXPERIMENTAL NEOPLASM; FEMALE; LETHALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL AVAILABILITY; CARCINOMA, LEWIS LUNG; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSSES, GENETIC; FEMALE; IFOSFAMIDE; INJECTIONS, SUBCUTANEOUS; LEUKEMIA L1210; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MOLECULAR STRUCTURE;

EID: 0034945173     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200106000-00006     Document Type: Article

References (28)

1. An overview of cyclophosphamide development and clinical applications
2. The role of chemotherapy in the treatment of adult soft tissue sarcomas
3. The role of ifosfamide in paediatric cancer
4. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates
5. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group
6. Antitumor activity evaluation of bromine-substituted analogues of ifosfamide
7. Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide
8. Synthesis and absolute configuration assignments of enantiomeric forms of ifosphamide, sulfosphamide, and trofosphamide
9. Asymmetric synthesis of enantiomeric cyclophosphamides
10. HPLC separation of enantiomers of bromofosfamide and its metabolites using a chiral stationary phase
11. 50
12. Volatile complexes of trialkyl phosphates and alkylphosphonates with protic acids
13. Reagents for organic synthesis
14. Crystal and molecular structure of (-)-(S)- and (+)-(R)-bromofosfamide
15. Effects of alkylating metabolites of ifosfamide and its bromo analogues on DNA of HeLa cells
16. Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities
17. PNU 157977: A new potent antitumor agent exhibiting low in vivo toxicity in mice injected with L1210 leukemia cells
18. Cytotoxic halogenoacrylic derivatives of distamycin A
19. Stereospecific synthesis of chiral metabolites of ifosfamide and their determination in the urine
20. Efficacy, toxicity, pharmacokinetics, and in vitro metabolism of the enantiomers of ifosfamide in mice
21. Urinary excretion of the enantiomers of ifosfamide and its inactive metabolites in children
22. Dechloroetylation of ifosfamide and neurotoxicity
23. Ifosfamide metabolite chloracetaldehyde causes renal dysfunction in vivo
24. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model
25. Cyclophosphamide versus ifosfamide: 'To use ifosfamide or not to use, that is the three-dimensional question'
26. Synergistic antitumour effects of chemoimmunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model